Affymax names Orwin to replace Morris as CEO - Reuters PDF Print
Reuters
T), for treatment of anemia in kidney dialysis patients. The companies said in June that late-stage trials of the drug had met their main goal but showed a

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.